Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . May 27th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Cellular Suicide - Apoptotic mechanisms a hallmark of liver cell damage in viral hepatitis
Thyroid Disease - Interferon doses don't cause thyroid disorder in chronic hepatitis C
Vaccine Response - High hepatitis C virus load negates effective response to hepatitis B vaccine
Viral Transmission - Nicaraguan study shows hospitalization a risk for viral hepatitis in young
End-Stage Kidney Disease - Agent renders hepatitis B vaccine more effective in hemodialysis patients
Finance - Company reports 2002 1Q pro forma results of 21 cents per share
Finance - Nabi's first quarter earnings in line with expectations
Hepatitis B - Drug cocktail prevents recurrence after liver transplant
Hepatitis C - Company achieves $3.75M development milestone in HepaSense joint venture
Hepatitis C - Schering-Plough reports results of clinical studies of Pegintron and Rebetol combination therapy for hepatitis C
Transplant Medicine - HIV patients have no progression of HIV after liver transplantation, Pitt study reports
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
